* hospitalization at the time of study recruitment. * any individual less than 50 years of age. the reason that the participants ≥50 years are being excluded from this study is because those who are ≥50 years have a higher risk of being symptomatic with covid-19 and have the potential for the greatest benefit. the disease appears to manifest differently in children and its occurrence is quite rare. * only those patients tested for covid-19 initially will be eligible to participate; therefore, anyone wanting to participate in the trial must have had a covid-19 test prior to enrollment/participation in the study. * any individual who is not capable of making independent decisions and who is considered cognitively impaired.

* hospitalization at the time of study recruitment. * any individual less than 50 years of age. the reason that the participants ≥50 years are being excluded from this study is because those who are ≥50 years have a higher risk of being symptomatic with covid-19 and have the potential for the greatest benefit. the disease appears to manifest differently in children and its occurrence is quite rare. * only those patients tested for covid-19 initially will be eligible to participate; therefore, anyone wanting to participate in the trial must have had a covid-19 test prior to enrollment/participation in the study. * any individual who is not capable of making independent decisions and who is considered cognitively impaired.

- hospitalization at the time of study recruitment. - any individual less than 50 years of age. the reason that the participants ≥50 years are being excluded from this study is because those who are ≥50 years have a higher risk of being symptomatic with covid-19 and have the potential for the greatest benefit. the disease appears to manifest differently in children and its occurrence is quite rare. - only those patients tested for covid-19 initially will be eligible to participate; therefore, anyone wanting to participate in the trial must have had a covid-19 test prior to enrollment/participation in the study. - any individual who is not capable of making independent decisions and who is considered cognitively impaired.

- hospitalization at the time of study recruitment. - any individual less than 50 years of age. the reason that the participants ≥50 years are being excluded from this study is because those who are ≥50 years have a higher risk of being symptomatic with covid-19 and have the potential for the greatest benefit. the disease appears to manifest differently in children and its occurrence is quite rare. - only those patients tested for covid-19 initially will be eligible to participate; therefore, anyone wanting to participate in the trial must have had a covid-19 test prior to enrollment/participation in the study. - any individual who is not capable of making independent decisions and who is considered cognitively impaired.